Cemiplimab Recommended for Advanced Cervical Cancer Rob Hicks, MBBS

https://www.medscape.com/viewarticle/cemiplimab-recommended-advanced-cervical-cancer-2026a1000lc2?src= The National Institute for Health and Care Excellence (NICE) has recommended cemiplimab (Libtayo, Regeneron) for adults with recurrent or metastatic cervical cancer that has progressed after platinum-based chemotherapy — offering a new option where treatment choices are limited.